973.0000 -21.00 (-2.11%)
NSE May 16, 2025 15:31 PM
Volume: 45,735
 

973.00
-2.11%
Prabhudas Lilladhar
Online pharmacy startup PharmEasy announced acquisition of THYROCARE Technologies, with a view to add diagnostic services in its digital offerings through biochemistry/pathology business. PharmEasy's parent company API...
Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.
More from Thyrocare Technologies Ltd.
Recommended